Ryan Motte, PharmD, CSP, reviewed the global cancer burden among men and its projected trajectory to 2050, highlighting the ...

For the millions of Americans currently suffering in silence, whether due to affordability or accessibility, AI will offer a ...

FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect ...

John O. Mascarenhas, MD, and Kapila Viges discuss how the latest research is transforming MPN care by aligning research with ...

Although intravitreal faricimab helped to decrease central subfield thickness (CST) in patients with eyes previously treated ...

You know that moment when life takes an unexpected turn? That’s exactly what happened when I started researching stem cell ...

When facing multiple myeloma, learning about the disease, understanding treatment options, and knowing how to deal with the ...

The high health care burden faced by individuals with hemophilia underscores the urgent need for innovative treatments and ...

In a comprehensive analysis of more than 100 clinical trials involving nearly 15,000 adults, researcher have found that there ...

Research presented at SABCS 2024 highlighted efforts to expand treatment options for early breast cancer as well as ...

By automating certain tasks, such as clinical documentation, AI allows healthcare providers to focus more on the patient ...